Sepsis in the Interventional Radiology Patient

Journal of Vascular and Interventional Radiology

Volumn 15, Issue 4, 2004, Pages 317-325

  Smith, Tony P ^a   Ryan, J Mark ^a   Niklason, Laura E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZTREONAM; CEFTRIAXONE; CEPHALOSPORIN; GENTAMICIN; PENICILLIN DERIVATIVE;

ANTIMICROBIAL THERAPY; HIGH RISK PATIENT; HUMAN; INFECTION CONTROL; INTERVENTIONAL RADIOLOGY; NEPHROTOXICITY; PRIORITY JOURNAL; RADIOLOGY DEPARTMENT; RESUSCITATION; REVIEW; SEPSIS; TREATMENT PLANNING;

EID: 1842558428     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000116188.30591.E4     Document Type: Article

References (82)

1. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Cared Medicine Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874.
2. Vincent J-L. Sepsis: the magnitude of the problem. In: Vincent J-L, Carlet J, Opal SM. The sepsis text. Boston: Kluwer Academic Publishers, 2002;1-9.
3. Martin MA. Epidemiology and clinical impact of gram negative sepsis. Infect Dis Clin North Am 1991; 5:739-754.
4. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-1554.
5. Angus DC, Linde-Zwirble WT, Lidcker J, Carcillo J, Pinsky MR. Epidemiology of sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310.
6. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999; 340:207-214.
7. Thomas L. Germs. N Engl J Med 1972; 287:553-555.
8. Hotchkiss RS, Karl IE. Medical progress: the pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150.
9. Cross AS, Opal SM. A new paradigm for the treatment of sepsis: is it time to consider combination therapy? Ann Intern Med 2003; 138:502-505.
10. Freeman BD, Natanson C. Anti-inflammatory therapies in sepsis and septic shock. Expert Opin Investig Drugs 2003; 9:1651-1663.
11. Stüber F. Genetic predisposition. In: Vincent J-L, Carlet J, Opal SM, eds. The sepsis text. Boston: Kluwer Academic Publishers, 2002;67-79.
12. Nasraway SA. The problems and challenges of immunotherapy in sepsis. Chest (Suppl) 2003; 123:451S-459S
13. Dellinger RP. Inflammation and coagulation: implications for the septic patient. Clin Infect Dis 2003; 36:1259-1265.
14. Kanus WA, Harrell FE, Fisher CJ, et al. The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis. JAMA 1993; 270:1233-1241.
15. Clemmer TP, Fisher CJ, Bone RC, et al. Hypothermia in the sepsis syndrome and clinical outcome. Crit Care Med 1992; 20:1395-1401.
16. Tal Y, Even I, Kugelman A, et al. The clinical significance of rigors in febrile children. Eur J Pediatr 1997; 156:457-459.
17. Neane PB, Kelton JG, Walker IR, et al. Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood 1980; 56:88-92.
18. Ryan JM, Ryan BM, Smith TP. Antibiotic Prophylaxis for the Interventional Radiologist. J Vasc Interv Radiol 2004 (in press).
19. Dravid VS, Gupta VS, Zegal HG, Morales AV, Rabinowitz B, Freiman DB. Investigation of antibiotic usage for vascular and nonvascular interventional procedures. J Vasc Interv Radiol 1998; 9:401-406.
20. Shenep JL, Morgan KA. Kinetics of endotoxin release during antibiotic therapy for experimental gram negative sepsis. J Infect Dis 1984; 150:380-388.
21. McDermott VG, Schuster MG, Smith TP. Antibiotic prophylaxis in vascular and interventional radiology. AJR Am J Roentgenol 1997; 169:31-38.
22. Spies JB, Lebowitz AS. Antibiotic prophylaxis in vascular and interventional radiology: a rational approach. Radiology 1988; 166:381-387.
23. Natanson C, Danner RL, Reilly JM, et al. Antibiotics versus cardiovascular support in a canine model of human septic shock. Am J Physiol 1990; 259: H1440-H1447.
24. Bodey GP, Jadeja L, Elting L. Pseudomonas bacteremia: retrospective analysis of 410 episodes. Arch Intern Med 1985; 145:1621-1629.
25. Pinder M, Bellomo R, Lipman J. Pharmacological principles of antibiotic prescription in the critically ill. Anaesth Intensive Care 2002; 30:134-144.
26. Fish DJ. Optimal antimicrobial therapy for sepsis. Am J Health Syst Pharm 2002; 15:S9-S13.
27. Bartal C, Dannon A, Schlaeffer F, et al. Pharmacokinetic dosing of aminoglycosides: a controlled trial. Am J Med 2003; 15:194-198.
28. Phillip DR. Cardiovascular management of septic shock. Crit Care Med 2003; 31:946-955.
29. Task Force of the American College of Critical Care, Society of Critical Care Medicine. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 1999; 27:639-660.
30. Freeman BD, Parrillo JE, Natanson C. Septic shock and multiple organ failure. In: Parrillo JE, Dellinger RP, eds. Critical care medicine: principles of diagnosis and management in the adult, 2nd ed. St Louis: Mosby, 2001;437-452.
31. Rackow EC, Falk JL, Fein IA. Fluid resuscitation in shock: a comparison of cardiorespiratory effects of albumin, hetastarch and saline solutions in patients with hypovolemic shock. Crit Care Med 1983; 11:839-850.
32. Choi PT-L, Yip G, Quinonez L, Cook DJ. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999; 27:200-210.
33. Ernest D, Belzber AS, Dodek PM. Distribution of normal saline and 5% albumin in septic patients. Crit Care Med 1999; 27:46-50.
34. Velanovich V. Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality. Surgery 1989; 105:65-71.
35. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomized trials. BMJ 1998; 316:961-964.
36. Herbert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340:409-417.
37. Rudis MI, Basha MA, Zarowitz BJ. Is it time to reposition vasopressors and inotropes in sepsis? Crit Care Med 1996; 24:525-537.
38. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med 2003; 31:946-955.
39. Martin C, Papazian L, Perrin G, Saux P, Gouin F. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 1993; 103: 1826-1831.
40. Chintanadilok J, Bender BS. Sepsis. In: Yoshikawa TT, Norman DC, eds. Infectious disease in the aging: a clinical handbook. Totowa: Humana Press, 2001;33-52.
41. Bellissant E, Annane D. Effect of hydrocortisone on phenylephrine-mean arterial pressure dose-response relationship in septic shock. Clin Pharmacol Ther 2000; 68:293-303.
42. Theilmeier G, Brooke M. Norepinephrine in septic patients-friend or foe? J Clin Anesth 2003; 15:154-158.
43. Meier-Hellmann A, Sakka S, Reinhart K. Supportive therapy of the sepsis syndrome. Clin Chem Lab Med 1999; 37:333-339.
44. Ruokonen E, Parviainen I, Uusaro A. Treatment of impaired perfusion in septic shock. Ann Med 2002; 34:590-597.
45. DeBacker D, Creteur J, Silva E, Vincent JL. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 2003; 31:1659-1667.
46. Kolmannskog K, Kolbenstvedt AN, Schrumpf E, et al. Side effects and complications after hepatic artery embolization in the carcinoid syndrome. Scand J Gastroenterol 1991; 26:557-562.
47. Chen C, Tsang TM, Hsueh PR, et al. Bacterial infections associated with hepatic arteriography and transarterial embolization for hepatocellular carcinoma: a prospective study. Clin Infect Dis 1999; 29:161-166.
48. Vashisht A, Studd J, Carey A, et al. Fatal septicaemia after fibroid embolization. Lancet 1999; 9175:307-308.
49. Soulen MC, Zaetta JM, Amygdalos MA, et al. Mechanical declotting of thrombosed dialysis grafts: experience in 86 cases. J Vasc Interv Radiol 1997; 8:563-567.
50. Minga TE, Flanagan KH, Allon M. Clinical consequences of infected arteriovenous grafts in hemodialysis patients. Am J Kidney Dis 2001; 38:975-978.
51. Hamlin JA, Friedman M, Stein MG, et al. Percutaneous biliary drainage: complications of 118 consecutive catheterizations. Radiology 1986; 158:199-202.
52. Gazzaniga GM, Faggioni A, Bondanza C, et al. Percutaneous transhepatic biliary drainage-twelve years' experience. Hepatogastroenterology 1991; 38: 154-160.
53. Mueller PR, vanSonnenberg E, Ferrucci JT. Percutaneous biliary drainage: technical and catheter-related problems in 200 procedures. AJR Am J Roentgenol 1982; 138:17-23.
54. Akhan O, Akinci D, Ozmen MN. Percutaneous cholecystostomy. Eur J Radiol 2002; 43:229-236.
55. Thomas J, Turner SR, Nelson RC, et al. Image-guided percutaneous drainage of hepatic abscesses: How often does post-procedure sepsis occur? (abstr). AJR Am J Roentgenol 2003; 180:44.
56. Zerman G, Bonfiglio M, Borzellino G, et al. Liver abscess due to acute cholecystitis. Report of five cases. Chir Ital 2003; 55:195-198.
57. Hadas-Halpern I, Patlas M, Knizhnik M, et al. Percutaneous cholecystostomy in the management of acute cholecystitis. Isr Med Assoc J 2003; 5:170-171.
58. Boland GW, Lee MJ, Leung J, et al. Percutaneous cholecystostomy in critically ill patients: early response and final outcome in 82 patients. AJR Am J Roentgenol 1994; 163:339-342.
59. England RE, McDermott VG, Smith TP, et al. Percutaneous cholecystostomy: who responds? AJR Am J Roentgenol 1997; 168:1247-1251.
60. Slater GJ, Dawson SL. Percutaneous drainage of pelvic abscesses and fluid collections. In: Baum S, Pentecost KJ, eds. Abrams' angiography: interventional radiology (vol III). Boston: Little, Brown, 1997;939-956.
61. Bissada AA, Bateman J. Pyogenic liver abscess: a 7 year experience in a large community hospital. Hepatogastroenterology 1991; 38:317-320.
62. Leung JW, Chan RC, Cheung SW, et al. The effect of obstruction on the biliary excretion of cefoperazone and ceftazidime. J Antimicrob Chemother 1990; 25:399-406.
63. Karatassas A, Williams JAR. Review of pyogenic liver abscess at the Royal Adelaide Hospital. Aust N Z J Surg 1990; 60:893-897.
64. Bishara J, Leibovici L, Huminer D, et al. Five-year prospective study of bacteraemic urinary tract infection in a single institution. Eur J Clin Infect Dis 1997; 16:563-567.
65. Zagoria RJ, Dyer RB. Do's and don't's of percutaneous nephrostomy. Acad Radiol 1999; 6:370-377.
66. McNicholas MMJ, Lee MJ, Dawson SL, et al. Complications of percutaneous biliary drainage and stricture dilatation. Semin Interv Radiol 1994; 11:242-253.
67. Lang EK, Price ET. Redefinitions of indications for percutaneous nephrostomy. Radiology 1983; 147:419-426.
68. Vehmas T, Kivisaari L, Mankinen P, et al. Results and complications of percutaneous nephrostomy. Ann Clin Res 1988; 20:423-427.
69. Lee WJ, Patel U, Patel S, et al. Emergency percutaneous nephrostomy: results and complications. J Vasc Interv Radiol 1994; 5:135-139.
70. Poduri RN, Dube DA, Weightman NC, Oppenheim BA, Morris J. Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol 1991; 146:955-960.
71. O'Keeffe NK, Mortimer AJ, Sambrook PA, et al. Severe sepsis following percutaneous or endoscopic procedures for urinary tract stones. Br J Urol 1993; 72:277-283.
72. Oberholzer K, Pitton MB, Mildenberger P, et al. The current value of percutaneous transhepatic biliary drainage. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002; 174: 1081-1088.
73. Cohan RH, Illescas FF, Saeed M, et al. Infectious complications of percutaneous biliary drainage. Invest Radiol 1986; 21:705-709.
74. Carrasco CH, Zornoza J, Bechtel WJ. Malignant biliary obstruction: complications of percutaneous biliary drainage. Radiology 1984; 152:343-346.
75. McAleer IM, Kaplan GW, Bradley JS, Carroll SF, Griffth DP. Endotoxin content in renal calculi. J Urol 2003; 169:1813-1814.
76. Schild H, Klose KJ, Staritz M, et al. The results and complications of 616 percutaneous transhepatic biliary drainages. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1989; 151: 289-293.
77. Gunther RW, Schild H, Thelen M. Percutaneous transhepatic biliary drainage: experience with 311 procedures. Cardiovasc Intervent Radiol 1988; 11:65-71.
78. Sacks-Berg A, Calubiran OV, Epstein HY, et al. Sepsis associated with transhepatic cholangiography. J Hosp Infect 1992; 20:43-50.
79. Yee ACN, Ho CS. Complications of percutaneous biliary drainage: benign vs. malignant diseases. AJR Am J Roentgenol 1987; 148:1207-1209.
80. Farrell TA, Hicks ME. A review of radiologically guided percutaneous nephrostomies in 303 patients. J Vasc Interv Radiol 1997; 8:769-774.
81. Goldberg SD, Gray RR, St. Louis EL, et al. Nonoperative management of complications of percutaneous renal nephrostomy. Can J Surg 1989; 32:192-195.
82. von der Recke PD, Nielsen MB, Pedersen JF. Complications of ultrasound-guided nephrostomy. A 5-year experience. Acta Radiol 1994; 35:452-454.